Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 15;185(4):356-62.
doi: 10.1164/rccm.201107-1317PP. Epub 2011 Nov 17.

Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program

Collaborators, Affiliations

Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program

Nizar N Jarjour et al. Am J Respir Crit Care Med. .

Abstract

The National Heart, Lung, and Blood Institute Severe Asthma Research Program (SARP) has characterized over the past 10 years 1,644 patients with asthma, including 583 individuals with severe asthma. SARP collaboration has led to a rapid recruitment of subjects and efficient sharing of samples among participating sites to conduct independent mechanistic investigations of severe asthma. Enrolled SARP subjects underwent detailed clinical, physiologic, genomic, and radiological evaluations. In addition, SARP investigators developed safe procedures for bronchoscopy in participants with asthma, including those with severe disease. SARP studies revealed that severe asthma is a heterogeneous disease with varying molecular, biochemical, and cellular inflammatory features and unique structure-function abnormalities. Priorities for future studies include recruitment of a larger number of subjects with severe asthma, including children, to allow further characterization of anatomic, physiologic, biochemical, and genetic factors related to severe disease in a longitudinal assessment to identify factors that modulate the natural history of severe asthma and provide mechanistic rationale for management strategies.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Comparison of physiological characteristics among adults with normal airways (n = 51), nonsevere asthma (n = 109), and severe asthma (n = 61), showing total lung capacity (box height), FEV1, and residual lung volume (RV). Note prominent air trapping (elevated RV) and airflow limitation (reduced FEV1) in severe asthma. Lung volumes are adjusted for differences due to height, age, sex, and race.
Figure 2.
Figure 2.
Chest multidetector computed tomography (MDCT) images and bronchial biopsy from subjects with mild and severe asthma. Chest MDCT scans were performed in (A) mild asthma and (B) severe asthma. A screen capture of the cross-sectional MDCT image demonstrates an outline of a central airway and reported average wall thickness. Note that the average wall thickness is significantly greater in the subject with severe asthma. Quantitative CT using the Pulmonary Workstation software (VIDA) allows accurate assessment of air trapping (defined as voxels within the lung field falling below −856 Hounsfield units) as demonstrated by sphericals proportional to area of air trapping (volume rendered view). Each lobe is color-coded. Note the increase in air trapping in all lobes of (D) the subject with severe asthma compared with (C) the subject with mild asthma. Representative images from hematoxylin-eosin sections from an endobronchial biopsy from (E) a subject with mild asthma and (F) a subject with severe asthma are demonstrated. The epithelial layer (Epi) and lamina reticularis (LR) are indicated. This histopathology demonstrates key features of airway remodeling that can now be correlated with quantitative imaging of the airways (airway wall thickness) and lungs (air trapping).
Figure 3.
Figure 3.
Cluster analysis of all adults with asthma in the Severe Asthma Research Program. BMI = body mass index; COPD = chronic obstructive pulmonary disease.

References

    1. Busse WW, Banks-Schlegel S, Wenzel SE. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000;106:1033–1042 - PubMed
    1. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000;162:2341–2351 - PubMed
    1. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003;22:470–477 - PubMed
    1. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 1991;88:425–534 - PubMed
    1. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:405–413 - PMC - PubMed

Publication types